The diagnostic process in ALS
- PMID: 10448975
- DOI: 10.1016/s0022-510x(99)00020-9
The diagnostic process in ALS
Abstract
A diagnosis of amyotrophic lateral sclerosis (ALS) is made by a process of elimination of other possible diseases. The time that elapses between the appearance of the first symptoms and diagnosis of ALS may be long, and may mean that the patient is passed from one specialist to another, or that the disease is misdiagnosed and treated incorrectly. It is likely that this period varies enormously in different countries, cultures and medical systems. An international survey was initiated to try and understand the relevant steps on the pathway to diagnosis of ALS, and to evaluate potential culture differences in this process. A pilot study was carried out in Germany, Spain and Sweden to evaluate the feasibility of the methodology. The pilot study showed that: (i) in most cases there was a long time lapse between the appearance of the patient's initial symptoms and their first visit to a general practitioner; (ii) there was often a long time lapse between the patient visiting a general practitioner and a neurologist; (iii) diagnosis was always made by a neurologist; and (iv) the time that elapsed before the neurologist announced the diagnosis to the patient differed from country to country. Education of general practitioners and other specialists about ALS is imperative. A follow-up study is now planned in various European countries and the USA to investigate whether similar results are found worldwide.
Similar articles
-
ISIS Survey: an international study on the diagnostic process and its implications in amyotrophic lateral sclerosis.J Neurol. 1999 Nov;246 Suppl 3:III1-5. doi: 10.1007/BF03161081. J Neurol. 1999. PMID: 10631652
-
Limb-onset amyotrophic lateral sclerosis patients visiting orthopedist show a longer time-to-diagnosis since symptom onset.BMC Neurol. 2013 Feb 9;13:19. doi: 10.1186/1471-2377-13-19. BMC Neurol. 2013. PMID: 23394455 Free PMC article.
-
Current treatment pathways in ALS: a European perspective.Neurology. 1999;53(8 Suppl 5):S4-10; discussion S20-1. Neurology. 1999. PMID: 10560630
-
How to improve the diagnostic process.J Neurol. 1999 Nov;246 Suppl 3:III6-9. doi: 10.1007/BF03161082. J Neurol. 1999. PMID: 10631653 Review.
-
Conceptual approach to diagnostic delay in ALS: a United States perspective.Neurology. 1999;53(8 Suppl 5):S17-9; discussion S20-1. Neurology. 1999. PMID: 10560632 Review.
Cited by
-
Cost effectiveness of treatments for amyotrophic lateral sclerosis: a review of the literature.Pharmacoeconomics. 2002;20(6):367-87. doi: 10.2165/00019053-200220060-00002. Pharmacoeconomics. 2002. PMID: 12052096 Review.
-
Vitamin D3 deficiency differentially affects functional and disease outcomes in the G93A mouse model of amyotrophic lateral sclerosis.PLoS One. 2011;6(12):e29354. doi: 10.1371/journal.pone.0029354. Epub 2011 Dec 27. PLoS One. 2011. PMID: 22216257 Free PMC article.
-
Carcinoma of the tongue and bulbar-onset amyotrophic lateral sclerosis: unusual differential diagnosis.Neurol Sci. 2007 Jun;28(3):151-3. doi: 10.1007/s10072-007-0809-x. Epub 2007 Jun 30. Neurol Sci. 2007. PMID: 17603768
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous